PhD Studentship: Machine Learning-Guided Engineering of Next-Generation Cancer Therapeutics

University of East Anglia

Norwich

On-site

GBP 20,000 - 24,000

Full time

14 days+

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

University of East Anglia invites applications for an interdisciplinary PhD project supervised by Dr Amit Sachdeva. The project aims to develop small, highly effective antibody fragments with improved penetration into solid tumours, using machine learning-guided design and expression in Escherichia coli.

Working at the chemistry, biology and AI interface, the successful candidate will gain extensive training in cutting-edge methodologies and contribute to next-generation biologic medicines while

Qualifications

  • 2:1 in Biological Sciences, Biochemistry, Chemical Biology or Chemistry.
  • Experience in laboratory skills relevant to recombinant protein work is desirable.
  • Interest in ML-guided protein design and cancer biology.

Responsibilities

  • Develop small antibody fragments with enhanced tumour penetration.
  • Clone, express and purify engineered antibody fragments in E. coli.
  • Evaluate binding to targets on cancer cells using established assays.
  • Incorporate non-canonical amino acids via synthetic biology approaches.

Skills

Machine learning approaches
Protein engineering / design

Education

2:1 in Biological Sciences, Biochemistry, Chemical Biology or Chemistry

Tools

Escherichia coli expression
Gel electrophoresis
Western blotting
Protein purification

Job description

Primary Supervisor - Dr Amit Sachdeva

Monoclonal antibodies have transformed the treatment of cancer by selectively recognising tumour-associated receptors and triggering cellular responses that lead to cancer cell death. Despite their clinical success, conventional full-length antibodies often show limited effectiveness against solid tumours because their large molecular size restricts deep penetration into tumour tissue. Overcoming this challenge represents a major opportunity in the development of next generation cancer therapeutics.

This interdisciplinary PhD project aims to develop small, highly effective antibody fragments capable of penetrating solid tumours more efficiently than conventional antibodies. The student will employ state-of-the-art machine learning approaches to design novel antibody fragments. These computationally engineered molecules will then be expressed in Escherichia coli. The project will involve cloning, expression and purification of engineered antibody fragments, followed by detailed biochemical and biophysical characterisation. Their binding affinity to the target will be evaluated on cancer cell lines, using our previously developed methods. Furthermore, the most promising candidates will be equipped with non-canonical amino acids through synthetic biology approaches, enabling the introduction of new chemical functionalities to improve targeting, and therapeutic performance.

Working at the interface of chemistry, biology, and artificial intelligence, the successful candidate will gain extensive training in cutting-edge methodologies including machine learning-guided protein design, molecular cloning, recombinant protein expression, protein purification, cell-based assays, gel electrophoresis, Western blotting and chemical protein modification techniques. The project offers a unique opportunity to contribute to the development of next-generation biologic medicines while acquiring a highly sought-after multidisciplinary skillset spanning chemical biology, synthetic biology, biotechnology, and cancer research.

This PhD is ideally suited to a highly motivated student in biochemistry, chemistry, molecular biology, biotechnology, or a related discipline who is excited by the prospect of applying computational and experimental approaches to address pressing challenges in cancer therapy.

Entry Requirements

The standard minimum entry requirement is 2:1 in Biological Sciences, Biochemistry, Chemical Biology, Chemistry, and related fields.

Mode of Study

Full-time

Start Date

1 October 2027

Additional Funding Information

This PhD project is in a competition for a Faculty of Science funded studentship. Funding is available to UK applicants and comprises ‘home’ tuition fees and an annual stipend for 3 years. The current UEA / institutional PhD stipend rate is £21,805 and will be subject to any agreed inflationary uplift for 2027/28.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

PhD: ML-Driven Antibody Fragments for Solid Tumors
PhD: ML-Driven Antibody Fragments for Solid Tumors

University of East Anglia • Norwich

On-site
GBP 20,000 - 24,000
PhD Studentship: New pharmacological tools for targeting P2X receptors in cancer
PhD Studentship: New pharmacological tools for targeting P2X receptors in cancer

University of East Anglia • Norwich

On-site
GBP 20,000 - 24,000
Funding for UK applicants
Annual stipend £21,805
AstraZeneca Non-Clinical PhD Studentship in Next-generation TPD for Oncology: Harnessing Ubiquitin-independent Pathways
AstraZeneca Non-Clinical PhD Studentship in Next-generation TPD for Oncology: Harnessing Ubiquitin-independent Pathways

University of Cambridge • Cambridge

On-site
GBP 18,000 - 21,000
PhD Studentship: Chemical Biology to target bacteria: Inhibiting bacterial growth by controlling cell division protein interactions
PhD Studentship: Chemical Biology to target bacteria: Inhibiting bacterial growth by controlling cell division protein interactions

University of East Anglia • Norwich

On-site
GBP 20,000 - 24,000
Fully funded PhD stipend
Tuition fees covered
Professional development programme
FSE PhD President's Doctoral Scholarship: Sensing BRCA2 Loss: Synthetic Antibodies for Precision Prostate Cancer Treatment
FSE PhD President's Doctoral Scholarship: Sensing BRCA2 Loss: Synthetic Antibodies for Precision Prostate Cancer Treatment

The University of Manchester • Manchester

On-site
GBP 20,000 - 24,000
PhD Studentship: How to build an immune receptor: AI-led protein design for engineering disease resistance
PhD Studentship: How to build an immune receptor: AI-led protein design for engineering disease resistance

University of East Anglia • Norwich

On-site
GBP 22,000 - 27,000
Tuition fees paid
Stipend £21,805 per year
RTSG £5,000 per year
PhD Studentship: Next-generation machine learning for genetic interaction prediction with lab-in the-loop validation in pancreatic cancer
PhD Studentship: Next-generation machine learning for genetic interaction prediction with lab-in the-loop validation in pancreatic cancer

University of Exeter • Exeter

On-site
GBP 20,000 - 24,000
Funded PhD studentship
Computational Research Assistant in Cancer Antigen Discovery and Prioritisation
Computational Research Assistant in Cancer Antigen Discovery and Prioritisation

University of Oxford • Oxford

On-site
GBP 36,000 - 40,000
Postdoctoral Researcher – AI Scientist & Computational Cancer Biology
Postdoctoral Researcher – AI Scientist & Computational Cancer Biology

University of Oxford • Oxford

On-site
GBP 39,000 - 48,000
PhD Studentship in Development of Pancreatic Tumour Treating Field System
PhD Studentship in Development of Pancreatic Tumour Treating Field System

RFCSR • Plymouth

On-site
GBP 18,000 - 21,000
Fully funded PhD studentship
Stipend in line with UKRI rates